Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Ro60 - Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases

Version 1 : Received: 12 June 2024 / Approved: 13 June 2024 / Online: 13 June 2024 (14:59:36 CEST)

A peer-reviewed article of this Preprint also exists.

Mahla, R.S.; Jones, E.L.; Dustin, L.B. Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases. Int. J. Mol. Sci. 2024, 25, 7705. Mahla, R.S.; Jones, E.L.; Dustin, L.B. Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases. Int. J. Mol. Sci. 2024, 25, 7705.

Abstract

The Ro60 autoantigen is an RNA-binding protein, and a core component of nucleocytoplasmic ribonucleoprotein (RNP) complexes. Ro60 is essential in RNA metabolism, cell stress response pathways, and cellular homeostasis. It stabilises and mediates quality control and cellular dis-tribution of YRNAs, retroelement transcripts, and misfolded RNAs. Ro60 transcriptional dysregulation or loss of function can result in the generation and release of RNA fragments from YRNAs and other small RNAs. Small RNA fragments can instigate an inflammatory cascade through endosomal TLRs and cytoplasmic RNA sensors, which typically sense patho-gen-associated molecular patterns (PAMPs) and mount the first line of defence against invading pathogens. However, recognition of host-originating RNA moieties from Ro60 RNP complexes can activate inflammatory response pathways and compromise self-tolerance. Autoreactive B cells may produce antibodies targeting extracellular Ro60 RNP complexes. Ro60 autoantibodies serve as diagnostic markers for various autoimmune diseases including Sjögren's disease (SjD) and systemic lupus erythematosus (SLE), and they may also act as predictive markers for an-ti-drug antibody response among rheumatic patients. Understanding Ro60’s structure, function, and role in self-tolerance can enhance our understanding of the underlying molecular mecha-nisms of autoimmune conditions.

Keywords

Ro60; inflammation; Sjögren’s Disease; RNA editing; autoantibodies; autoimmunity

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.